Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.

Ndembi, N; Ndembi, N; Goodall, RL; Dunn, DT; McCormick, A; Burke, A; Lyagoba, F; Munderi, P; Katundu, P; Kityo, C; +9 more... Robertson, V; Yirrell, DL; Walker, AS; Gibb, DM; Gilks, CF; Kaleebu, P; Pillay, D; Development of Antiretroviral Treatment in Africa Virology Group, H; ]; (2010) Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. The Journal of infectious diseases, 201 (1). pp. 106-13. ISSN 0022-1899 DOI: https://doi.org/10.1086/648590

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1086/648590

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar